Patents by Inventor Thomas Merigan

Thomas Merigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Publication number: 20070141565
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: February 6, 2007
    Publication date: June 21, 2007
    Inventors: Michael Kozal, Thomas Merigan, David Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acouired immunodeficiency syndrome
    Publication number: 20060110726
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: January 23, 2006
    Publication date: May 25, 2006
    Inventors: Michael Kozal, Thomas Merigan, David Katzenstein, Mark Holodniy
  • Compositions and treatment for herpes simplex
    Patent number: 5149529
    Abstract: A method for preventing or ameliorating HSV infection in a bird or mammal comprises administering a composition comprising an effective amount of an HSV surface glycoprotein and an effective amount of an MDP equivalent, encapsulated in liposomes. The resulting composition is useful for reducing the severity and recurrence of HSV outbreaks.
    Type: Grant
    Filed: October 11, 1991
    Date of Patent: September 22, 1992
    Assignees: Board of Trustees of Leland Chiron Corporation, Stanford Junior University
    Inventors: Rodney Ho, Thomas Merigan, Rae L. Burke, Dino Dina